(Q37960432)

26 August 2017

title

Quaternary ammonium salts and their antimicrobial potential: targets or nonspecific interactions? (English)

1 reference

26 August 2017

Ulrike Holzgrabe

4

0 references

Gabriele Pradel

series ordinal

2

object named as

Gabriele Pradel

1 reference

26 August 2017

Maximilian Tischer

1

1 reference

26 August 2017

Knut Ohlsen

series ordinal

3

1 reference

26 August 2017

language of work or name

1 reference

24 November 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

7

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

22-31

1 reference

Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Toxicity of the mitochondrial poison dequalinium chloride in a murine model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Dequalinium induces human leukemia cell death by affecting the redox balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Effects of the antitumoural dequalinium on NB4 and K562 human leukemia cell lines. Mitochondrial implication in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Effect of dequalinium on the oxidative stress in Plasmodium berghei-infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Plasmodium berghei: in vitro and in vivo activity of dequalinium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Synthesis and quantitative structure-activity relationship of a novel series of small conductance Ca(2+)-activated K+ channel blockers related to dequalinium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Synthesis and structure-activity relationships of dequalinium analogues as K+ channel blockers. Investigations on the role of the charged heterocycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Disintegration of amyloid fibrils of alpha-synuclein by dequalinium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Selective antimitochondrial agents inhibit calmodulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Mitochondrial DNA metabolism targeting drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

THE BACTERICIDAL ACTION OF SYNTHETIC DETERGENTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Sensitivity of Pseudomonas aeruginosa Envelope Mutants to Alkylbenzyldimethylammonium Chlorides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Dimers of nostocarboline with potent antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Structure and evolution of a family of genes encoding antiseptic and disinfectant resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Mode-of-action studies of the novel bisquaternary bisnaphthalimide MT02 against Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Solution structure and dynamics of a complex between DNA and the antitumor bisnaphthalimide LU-79553: intercalated ring flipping on the millisecond time scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Indirect effects modulating the interaction between DNA and a cytotoxic bisnaphthalimide reveal a two-step binding process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Peptide antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Glycerophospholipid acquisition in Plasmodium - a puzzling assembly of biosynthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Phospholipid metabolism of serine in Plasmodium-infected erythrocytes involves phosphatidylserine and direct serine decarboxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Increased permeability to choline in simian erythrocytes after Plasmodium knowlesi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Choline uptake into the malaria parasite is energized by the membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Inhibitors of choline transport into Plasmodium-infected erythrocytes are effective antiplasmodial compounds in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Antimalarial activity of molecules interfering with Plasmodium falciparum phospholipid metabolism. Structure-activity relationship analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Potent antimalarial activity of 2-aminopyridinium salts, amidines, and guanidines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Synthesis and evaluation of hybrid bis-cationic salts as antimalarial drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

A class of potent antimalarials and their specific accumulation in infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

In vivo antimalarial activities of mono- and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Mono- and bis-thiazolium salts have potent antimalarial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Synthesis and evaluation of bis-thiazolium salts as potential antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Antimalarial effect of bis-pyridinium salts, N,N'-hexamethylenebis(4-carbamoyl-1-alkylpyridinium bromide).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Antimalarial cation-dimers synthesized in two steps from an inexpensive starting material, isonicotinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Potent and selective antiplasmodial activity of the cyanobacterial alkaloid nostocarboline and its dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Antimalarial and antitubercular nostocarboline and eudistomin derivatives: synthesis, in vitro and in vivo biological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

The bisnaphthalimides as new active lead compounds against Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Heme binding contributes to antimalarial activity of bis-quaternary ammoniums

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

A systematic approach to understand the mechanism of action of the bisthiazolium compound T4 on the human malaria parasite, Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Comparison of the cellular and biochemical properties of Plasmodium falciparum choline and ethanolamine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Synthesis, antifungal and haemolytic activity of a series of bis(pyridinium)alkanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

Antiseptics and disinfectants: activity, action, and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Salts of decamethylene-bis-4-aminoquinaldinium (dequadin); a new antimicrobial agent

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Dequalinium induces cell death in human leukemia cells by early mitochondrial alterations which enhance ROS production

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Inhibition of protein kinase C by dequalinium analogues: structure-activity studies on head group variations

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Inhibition of protein kinase C(alpha) by dequalinium analogues: dependence on linker length and geometry

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Synthesis and Quantitative Structure-Activity Relationship of Dequalinium Analogs as K+ Channel Blockers: Investigations on the Role of the Substituent at Position 4 of the Quinoline Ring

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Synthesis and pharmacological testing of dequalinium analogues as blockers of the apamin-sensitive Ca(2+)-activated K+ channel: variation of the length of the alkylene chain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Synthesis, molecular modeling, and K+ channel-blocking activity of dequalinium analogues having semirigid linkers

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Antimicrobial and toxic effect in vitro of a bisdequalinium acetate solution for endodontic use

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

The antibacterial activity of new derivatives of 4-aminoquinoline and 4-aminoquinaldine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

The adsorption of cetyltrimethylammonium bromide by bacteria, its action in releasing cellular constituents and its bactericidal effects

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Electron microscopy of bacteria treated with cetyltrimethylammonium bromide

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Reverse-benzamidine antimalarial agents: design, synthesis, and biological evaluation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100404

7 January 2021

Identifiers

DOI

10.1002/CMDC.201100404

1 reference

release_y5aumw2nfffezmfgzhvaiugvqu

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y5aumw2nfffezmfgzhvaiugvqu

24 November 2022

mapped directly with Wikidata item

1 reference